Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform.
Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
HappyVore cultivates a passion for taste, the real, the healthy, and the impact on the planet.
MOMA Therapeutics operates as a biotechnology company.
Learn In is an upskilling-as-a-service platform that connects employers and learners.
Marlette Funding is a financial tech company tasked to empower customers.
Wiloki is an innovative and motivating platform for children and teenagers aged 7 to 14.
Repertoire Immune Medicines is a clinical stage biotechnology company.
Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.
Faze Medicines is a biotechnology company.
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Enwise is a provider of early education for children.
Triplet is developing transformative therapies that treat repeat expansion disorders at their source.
Thrive Market is a membership-based online company that offers natural and organic food products.
Tea Monsters is a robotic tea production workstation.
Rebound Therapeutics is a medical device company.
CardioGard develops a specially designed arterial cannula for the removal of gaseous material during heart bypass surgeries.
Invus has invested in 117 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Education. The firm invests across 40 different industry categories.
Among tracked funding rounds, Orbital Therapeutics received $270.0M in a Series A round. Invus's total known invested capital is $9.5B.
Invus's average investment size is $93.6M across its portfolio of 117 companies.
Recent Invus portfolio additions include Presidio Medical, Cyclerion Therapeutics, Ikena Oncology, Orbital Therapeutics, Ring Therapeutics. These companies were founded in 2020 or later.